Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

The Quest for a COVID-19 Vaccine

WEBINAR

Only

The Quest for a COVID-19 Vaccine

Tuesday, February 2, 2021, 10:30 AM - Wednesday, February 3, 2021, 5:35 PM EST

Webinar

Presented By

 

The world is undergoing a global public health disaster unlike anything experienced since the 1918 influenza pandemic.  COVID-19 disease — which emerged from the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) — rapidly has spread from person to person across all borders.  With no “silver bullet” treatment currently available, the novel coronavirus pandemic has caused substantial morbidity and mortality worldwide.

Scientific researchers therefore are racing at an unprecedented pace to develop a vaccine against SARS-CoV-2.  The importance of vaccines is two-fold: they prevent disease in the individual receiving the inoculation and the best vaccines are also able to block a pathogen’s transmission from person to person.  Academia, biotechnology, and government have swiftly mobilized to develop candidate vaccines for SARS-CoV-2.  The field of vaccinology has demonstrated significant innovation in harnessing both traditional vaccine techniques and cutting-edge/not-yet-proven strategies as they seek to build an effective vaccine for SARS-CoV-2.  The sheer number of groups developing a vaccine, the diversity of candidate vaccines being explored, the range of technology platforms, and the enormous financial investment into these activities are all historic and will hopefully lead to one or more efficacious licensed vaccines in the near future.  While there is much promise that this will occur, critical open questions and hurdles remain.

The world is waiting for a SARS-CoV-2 vaccine and hoping that it will help control the current pandemic.  Moreover, the development of such a vaccine will be the fastest in history and will open new innovation windows that we can learn from for the future.  This conference will provide a neutral forum to explore recent achievements and challenges in the development of a vaccine against SARS-CoV-2.  Through a series of keynote and plenary presentations, major themes to be considered for the program include:

  • the public health and clinical epidemiology of COVID-19
  • the virology, immunology, and genetics of SARS-CoV-2,
  • efficacy data updates from candidate vaccines in Phase 3 trials,
  • updates from Phase 1 and 2 vaccine candidates,
  • COVID-19 vaccines in the elderly,
  • outbreak predictions, and
  • future considerations for the development and distribution of a COVID-19 vaccine

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$130
Nonmember Corporate, Other
$170
Nonmember Not for Profit
$130
Nonmember Student, Undergrad, Grad, Fellow
$90
Member Student, Post-Doc, Fellow
$30

Scientific Organizing Committee

Annaliesa Anderson, PhD
Annaliesa Anderson, PhD

Pfizer

Greg Glenn, MD
Greg Glenn, MD

Novavax

Emmanuel Hanon, PhD
Emmanuel Hanon, PhD

GlaxoSmithKline

Wayne Koff, PhD
Wayne Koff, PhD

Human Vaccines Project

Stanley Plotkin, MD
Stanley Plotkin, MD

University of Pennsylvania / Vaxconsult

Melanie Brickman Borchard, PhD, MSc
Melanie Brickman Borchard, PhD, MSc

New York Academy of Sciences

Keynote Speaker

Moncef Slaoui
Moncef Slaoui, PhD

Operation Warp Speed

Speakers

Tal Zaks
Tal Zaks

Moderna

Mark Woolhouse
Mark Woolhouse, FRSE FMedSci OBE

The University of Edinburgh

Melanie Saville
Melanie Saville, MD

CEPI

Jerald Sadoff, MD
Jerald Sadoff, MD

Janssen Pharmaceutical Companies of Johnson & Johnson

Bali Pulendran
Bali Pulendran, PhD

Stanford University

Stefan O. Mueller, PhD
Stefan O. Mueller, PhD

CureVac

Bette Korber, PhD
Bette Korber, PhD

Los Alamos National Laboratory

J. Joseph Kim
J. Joseph Kim

Inovio Pharmaceuticals

Kathrin Jansen, PhD
Kathrin Jansen, PhD

Pfizer

Greg Glenn, MD
Greg Glenn, MD

Novavax

Sarah Gilbert, PhD
Sarah Gilbert, PhD

University of Oxford

Peter Daszak, PhD
Peter Daszak, PhD

EcoHealth Alliance

Nir Barzalai, MD
Nir Barzalai, MD

Albert Einstein College of Medicine

Ralph Baric, PhD
Ralph Baric, PhD

University of North Carolina

Annaliesa Anderson, PhD
Annaliesa Anderson, PhD

Pfizer

Tuesday

February 02, 2021

10:30 AM

WELCOME REMARKS

Speaker

Melanie Brickman Borchard, PhD, MSc
New York Academy of Sciences
10:40 AM

KEYNOTE ADDRESS

Speaker

Moncef Slaoui, PhD
Operation Warp Speed
11:25 AM

Break

SESSION I: Epidemiology of COVID-19

Session Chairperson
Chairperson to Be Announced
11:35 AM

Global Epidemiology of the COVID-19 Pandemic

Speaker

Speaker to be announced
12:05 PM

Tracking Changes in SARS-CoV-2 Spike

Speaker

Bette Korber, PhD
Los Alamos National Laboratory

SESSION II: Virology, Immunology, & Genetics of SARS-CoV-2

12:35 PM

Virology of SARS-CoV-2

Speaker

Ralph Baric, PhD
University of North Carolina
1:05 PM

Immunology of SARS-CoV-2

Speaker

Shane Crotty, PhD
La Jolla Institute for Immunology
1:35 PM

Break

2:20 PM

Longitudinal Immune Profiling of Moderate and Severe COVID-19

Speaker

Bali Pulendran, PhD
Stanford University

Session III: Efficacy Studies, Part 1

Session Chairperson
Chairperson to Be Announced
2:50 PM

Efficacy Data Updates from Novavax’s Protein-based Vaccine Candidate

Speaker

Greg Glenn, MD
Novavax
3:20 PM

Efficacy Data Updates from Pfizer’s mRNA Vaccine Candidate

Speaker

Kathrin Jansen, PhD
Pfizer
3:50 PM

Break

4:00 PM

Efficacy Data Updates from Moderna’s mRNA Vaccine Candidate

Speaker

Tal Zaks, MD, PhD
Moderna
4:30 PM

Efficacy Data Updates

Speaker

Speaker to be announced

SESSION IV: Update Talks

Session Chairperson
Chairperson to Be Announced
5:00 PM

Updates

Speaker

Speaker to be announced
5:15 PM

Updates from Inovio Pharmaceutical’s DNA Vaccine Candidate

Speaker

J. Joseph Kim
Inovio Pharmaceuticals
5:30 PM

Closing Remarks, Day 1

5:35 PM

End of Day

Wednesday

February 03, 2021

WELCOME REMARKS

Speaker

Melanie Brickman Borchard, PhD, MSc
New York Academy of Sciences

SESSION V: Efficacy Studies, Part 2

Session Chairperson
Chairperson to Be Announced
10:35 AM

Efficacy Data Updates from AstraZeneca’s Viral-Vector Vaccine Candidate

Speaker

Sarah Gilbert, PhD
University of Oxford
11:05 AM

Efficacy Data Updates from CanSino Biologics’ Viral-Vector Vaccine Candidate

Speaker

Xuefeng Yu, PhD, CanSino Biologics
11:35 AM

Break

11:45 AM

Efficacy Data Updates from Johnson & Johnson’s Viral-Vector Vaccine Candidate

Speaker

Jerald Sadoff, MD
Crucell Vaccine Institute, Janssen Pharmaceutical Companies of Johnson & Johnson

SESSION VI: Update Talks

Session Chairperson
Chairperson to Be Announced
12:15 PM

Updates from GlaxoSmithKline’s Vaccine Candidate

Speaker

Speaker to be announced
GlaxoSmithKline
12:45 PM

Updates from CureVac’s Messenger RNA (mRNA)-based Covid-19 Vaccine Candidate

Speaker

Stefan O. Mueller, PhD
CureVac
1:00 PM

Updates

Speaker

Speaker to be announced
1:15 PM

Updates

Speaker

Speaker to be announced
1:30 PM

Break

SESSION VII: COVID-19 Vaccines in the Elderly

Session Chairperson
Chairperson to Be Announced
2:15 PM

Immunosenescence and COVID-19 Vaccines for the Elderly

Speaker

Nir Barzalai, MD
Albert Einstein College of Medicine

SESSION VIII: Outbreak Predictions

Session Chairperson
Chairperson to Be Announced
2:45 PM

How to Make Predictions about Future Infectious Disease Risks

Speaker

Mark Woolhouse, FRSE FMedSci OBE
The University of Edinburgh
3:15 PM

Challenges to Prediction and Prevention of the Next Pandemic Zoonosis

Speaker

Peter Daszak, PhD
EcoHealth Alliance

SESSION IX: Future Considerations

Session Chairperson
Chairperson to Be Announced
3:45 PM

Progress in Novel Treatments for COVID-19 and Beyond

Speaker

Annaliesa Anderson, PhD
Pfizer
4:15 PM

Lessons Learned from COVID-19 Vaccine Development for Future Pandemic Preparedness

Speaker

Melanie Saville, MD
CEPI
4:45 PM

How Will a Vaccine Impact Our Futures?

Speaker

Speaker to be announced
5:35 PM

Closing Remarks, Day 2

Speaker

Melanie Brickman Borchard, PhD, MSc
New York Academy of Sciences
5:40 PM

End of Conference